Policybanaoo.com No1 Insurance company in India

Call Us: +919620062500

(Mon - Friday)

Mail us for help:

support@policybanaoo.com

3C, Third Floor 24, Tanoshi Building,

Kasavanahalli , Bengaluru

Month: February 2025

FDA Approves BV+R2 Combo for R/R LBCL

FDA Approves BV+R2 Combo for R/R LBCL

The US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for brentuximab vedotin (Adcetris; Seagen, Inc., a Pfizer subsidiary), in combination with lenalidomide and rituximab, for adults with large B-cell lymphoma that recurs or fails to respond to at least two prior lines of therapy…Read More
Read more
Transplant Recipients Face High Risk for Actinic Keratosis

Transplant Recipients Face High Risk for Actinic Keratosis

TOPLINE: About 1 in 15 solid organ transplant patients per year develop actinic keratosis (AK), with men, White individuals, and lung transplant recipients at highest risk. METHODOLOGY: Data analysis was performed on 5484 solid organ transplant (SOT) recipients (mean age, 56.9 years; 61.6% men) from Optum’s deidentified Clinformatics Data Mart…Read More
Read more
Small Town Offers Big Perks to Attract a Physician

Small Town Offers Big Perks to Attract a Physician

HAVANA, Fla. — For a rural community, this town of 1750 people has been more fortunate than most. A family doctor has practiced here for the last 30 years. But that ended in December when Mark Newberry retired. To attract a new doctor, Havana leaders took out want ads in local newspapers…Read More
Read more
How Bad Will It Get? Flu Rates Are Still Rising

How Bad Will It Get? Flu Rates Are Still Rising

Nearly one in three people getting tested for the flu are hearing back from their health care provider that it’s positive.  Nearly 8% of all outpatient clinic visits are being linked to people seeking treatment for what health officials call “flu-like illness,” meaning having the symptoms of fever and coughing or a sore throat…Read More
Read more
Weight Loss Drug Curbs Alcohol Cravings, Consumption

Weight Loss Drug Curbs Alcohol Cravings, Consumption

Once-weekly subcutaneous injections of semaglutide (Ozempic, Novo Nordisk) reduced alcohol cravings and consumption in adults with alcohol use disorder (AUD), findings from a small phase 2 placebo-controlled trial showed. The findings add to preclinical, observational, and pharmacoepidemiology evidence suggesting that the glucagon-like peptide 1 receptor agonist (GLP-1 RA) and similar medications may reduce alcohol intake […]
Read more